Entering text into the input field will update the search result below

Agenus Inc. (AGEN) Q1 2023 Earnings Call Transcript

May 09, 2023 11:33 AM ETAgenus Inc. (AGEN)
SA Transcripts profile picture
SA Transcripts

Agenus Inc. (NASDAQ:AGEN) Q1 2023 Earnings Conference Call May 9, 2023 8:30 AM ET

Company Participants

Zack Armen - Head, IR

Dr. Garo Armen - Chairman & CEO

Dr. Steven O'Day - Chief Medical Officer

Christine Klaskin - Vice President of Finance

Conference Call Participants

Emily Bodnar - H.C. Wainwright

Mike King - EF Hutton

Mayank Mamtani - B. Riley

Matt Phillips - William Blair


Good day, and welcome to the Agenus First Quarter 2023 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] And finally, I would like to advise all participants that this call is being recorded.

I'd now like to welcome Mr. Zach Arman to begin the conference. Zach, over to you.

Zack Armen

Thank you, operator, and thank you all for joining us today. Today's call is being webcast and will be available on our website for replay.

I'd like to remind you that this call will include forward-looking statements, including statements regarding our clinical development, regulatory and commercial plans and time lines, as well as time lines for data release and partnership opportunities. These statements are subject to risks and uncertainties, and we refer you to our SEC filings for more details on these risks.

Joining me today are Dr. Garo Armen, Chairman and Chief Executive Officer; Dr. Steven O'Day, Chief Medical Officer; and Christine Klaskin, Vice President of Finance.

Now, I'd like to turn the call over to Garo to highlight our progress and speak to our outlook for the remainder of the year. Garo?

Dr. Garo Armen

Good morning, everyone, and thank you for joining us for our first quarter 2023 update. Today, we'll primarily focus on the significant progress we've made with our groundbreaking botensilimab program

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.